CJC-1295 with DAC 5 mg — Lyophilized Vial 5 mg · 1 vial
$69.00
CJC-1295 with DAC: long-acting ghrh and gh/igf-1 signaling. CJC-1295 with DAC is a modified GHRH analog designed for prolonged activity. For laboratory research use only.
In stock
For laboratory research only. Not for human or veterinary use.
What is CJC-1295 with DAC?
CJC-1295 with DAC is a modified GHRH analog designed for prolonged activity. DAC refers to a drug-affinity-complex modification that supports binding to circulating albumin.
Biological activity
Albumin binding prolongs exposure compared with short-acting GHRH analogs. Human research has measured sustained changes in growth hormone and IGF-1 following administration of the studied CJC-1295 compound.
Purpose and areas of study
Researchers use this long-acting analog to examine the GH/IGF-1 axis, hormone secretion over time and the consequences of extended GHRH stimulation. Its defining feature is prolonged endocrine signaling, not direct replacement with growth hormone.
Evidence context
Endocrine activity of a studied compound does not demonstrate muscle growth, fat loss or recovery benefits for this research vial.
Product presentation
One lyophilized vial. Labeled content: 5 mg.
Scientific references
Research-use information
All information on this page is provided for scientific education and research purposes only. This product is intended exclusively for laboratory research and is not for human or veterinary use. The information is not medical advice or a claim of therapeutic benefit.
There are no reviews yet. Be the first!
Related Products
CJC-1295 with DAC 5 mg — Lyophilized Vial$69.00